Virtus ETF Advisers LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 101 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$380,000
-23.4%
104,662
-8.4%
0.17%
-18.1%
Q2 2021$496,000
+57.5%
114,256
+24.2%
0.20%
+53.4%
Q1 2021$315,000
-0.3%
91,971
+1.8%
0.13%
+1.5%
Q4 2020$316,000
-23.1%
90,356
-47.2%
0.13%
-39.4%
Q3 2020$411,000
+15.4%
171,235
-12.0%
0.22%
+27.8%
Q2 2020$356,000
+41.3%
194,583
+20.7%
0.17%
+62.5%
Q1 2020$252,000
-36.2%
161,235
-12.7%
0.10%
+60.0%
Q4 2019$395,000
-47.4%
184,740
-21.1%
0.06%
-16.7%
Q3 2018$751,000
+21.7%
234,017
+7.4%
0.08%
-85.7%
Q2 2018$617,000
-18.2%
217,985
+2.4%
0.54%
-16.7%
Q1 2018$754,000
+96.9%
212,882
+115.6%
0.65%
+36.0%
Q4 2017$383,000
+19.3%
98,726
-21.9%
0.48%
+1018.6%
Q3 2017$321,000
+2.6%
126,385
+10.1%
0.04%
-8.5%
Q2 2017$313,000
-15.9%
114,825
+2.2%
0.05%
-28.8%
Q1 2017$372,000
+53.7%
112,403
+10.6%
0.07%
-8.3%
Q4 2016$242,000101,6280.07%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders